Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The myosin VB pseudogene (ENSG00000267591) is classified as a pseudogene—a type of non-functional genomic locus that shares sequence similarity with the functional myosin VB (MYO5B) gene but has acquired disabling mutations or structural changes that prevent it from producing a functional protein[1]. Pseudogenes can be categorized as unitary, unprocessed (duplicated), or processed, with the latter formed via retrotransposition[1]. Pseudogenes, including the myosin VB pseudogene, do not encode functional proteins and are not considered therapeutic targets, receptors, enzymes, or active members of molecular families relevant for drug discovery or clinical decision-making[1]. While functional MYO5B is a class V myosin involved in intracellular cargo transport along actin filaments[2], the pseudogene form does not contribute to these or other biological functions. Pseudogenes may sometimes play regulatory roles or serve as markers in evolutionary, genomic, or transcriptomic analysis, but they are not drug targets and generally lack known roles in disease or clinical biomarkers[1]. There is nothing misspelled in the entry, but as a pseudogene, "myosin VB pseudogene" is often not relevant as a therapeutic or research target, and it should not be confused with the functional MYO5B gene or protein. For the pseudogene itself, there is no known role in disease, pharmacology, or clinical utility[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin VB pseudogene.